Albany Shaker Dental Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 399 Albany Shaker Rd, Loudonville, NY 12211 Phone: 518-438-1131 |
Lasting Impressions Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 399 Albany Shaker Rd Ste 201, Loudonville, NY 12211 Phone: 518-438-1131 |
Abdentistrypllc Dentist Medicare: Not Enrolled in Medicare Practice Location: 515 1/2 Albany Shaker Rd, Loudonville, NY 12211 Phone: 518-458-1320 Fax: 518-458-9670 |
Albany Advanced Dental Care Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 562 Albany Shaker Rd, Loudonville, NY 12211 Phone: 518-458-1620 Fax: 518-458-2190 |
News Archive
Cybex International, Inc., a leading manufacturer of premium exercise equipment, today reported results for its first quarter ended March 26, 2011. Net sales for the first quarter of 2011 increased by 19% to $31.0 million compared to $26.1 million for the corresponding 2010 period.
Researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Roswell Park Cancer Institute have received an $8 million grant from the National Cancer Institute (NCI) to study the effects of photodynamic light therapy (PDT) in patients with malignant pleural mesothelioma, a rare, aggressive and deadly cancer that most often manifests itself in the lining of the lungs and is caused almost exclusively by exposure to asbestos.
Professor Mark McGurk speaks to News-Medical about his groundbreaking research that has led to the discovery of a world-first treatment for oral cancer.
New research uncovers two genetic regions that influence birth weight. One of the regions is also associated with type 2 diabetes, which helps to explain why small babies have higher rates of diabetes in later life.
Isis Innovation, the University of Oxford's technology commercialisation company, and Ludwig Cancer Research are proud to announce the launch of a new spinout company, iOx Therapeutics. iOx Therapeutics will develop a novel cancer immunotherapy discovered through a collaboration between Ludwig Cancer Research and Professor Vincenzo Cerundolo, the director of the MRC Human Immunology Unit within the University of Oxford's Weatherall Institute of Molecular Medicine.
› Verified 6 days ago